LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 91 filers reported holding LEGEND BIOTECH CORP in Q3 2021. The put-call ratio across all filers is 0.88 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $376,920 | +11.5% | 5,604 | +14.6% | 0.00% | – |
| Q2 2023 | $338,070 | +43.5% | 4,892 | 0.0% | 0.00% | – |
| Q1 2023 | $235,661 | +60.3% | 4,892 | +65.8% | 0.00% | – |
| Q4 2022 | $146,969 | +21.5% | 2,951 | 0.0% | 0.00% | – |
| Q3 2022 | $121,000 | +33.0% | 2,951 | +78.5% | 0.00% | – |
| Q2 2022 | $91,000 | -7.1% | 1,653 | -38.9% | 0.00% | – |
| Q1 2022 | $98,000 | -22.2% | 2,705 | 0.0% | 0.00% | – |
| Q4 2021 | $126,000 | +4100.0% | 2,705 | +3937.3% | 0.00% | – |
| Q3 2021 | $3,000 | 0.0% | 67 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | +50.0% | 67 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 67 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 67 | +1.5% | 0.00% | – |
| Q3 2020 | $2,000 | -94.6% | 66 | -92.4% | 0.00% | – |
| Q2 2020 | $37,000 | – | 865 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 526,072 | $21,595,000 | 11.36% |
| Consonance Capital Management LP | 1,647,497 | $67,630,000 | 8.14% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,629,173 | $66,878,000 | 6.84% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,342,442 | $55,107,000 | 2.29% |
| Vivo Capital, LLC | 956,702 | $39,273,000 | 1.70% |
| Hudson Bay Capital Management LP | 1,878,374 | $77,107,000 | 0.93% |
| Capital International Sarl | 220,470 | $9,050,000 | 0.78% |
| Capital International, Inc./CA/ | 1,951,845 | $80,123,000 | 0.72% |
| Avidity Partners Management LP | 625,000 | $25,656,000 | 0.69% |
| INDUS CAPITAL PARTNERS, LLC | 94,678 | $3,887,000 | 0.66% |